Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin - PubMed (original) (raw)
Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin
Gregory J Hurteau et al. Cancer Res. 2007.
Abstract
MicroRNAs are approximately 22-nucleotide sequences thought to interact with multiple mRNAs resulting in either translational repression or degradation. We previously reported that several microRNAs had variable expression in mammalian cell lines, and we examined one, miR-200c, in more detail. A combination of bioinformatics and quantitative reverse transcription-PCR was used to identify potential targets and revealed that the zinc finger transcription factor transcription factor 8 (TCF8; also termed ZEB1, deltaEF1, Nil-2-alpha) had inversely proportional expression levels to miR-200c. Knockout experiments using anti-microRNA oligonucleotides increased TCF8 levels but with nonspecific effects. Therefore, to investigate target predictions, we overexpressed miR-200c in select cells lines. Ordinarily, the expression level of miR-200c in non-small-cell lung cancer A549 cells is low in contrast to normal human bronchial epithelial cells. Stable overexpression of miR-200c in A549 cells results in a loss of TCF8, an increase in expression of its regulatory target, E-cadherin, and altered cell morphology. In MCF7 (estrogen receptor-positive breast cancer) cells, there is endogenous expression of miR-200c and E-cadherin but TCF8 is absent. Conversely, MDA-MB-231 (estrogen receptor-negative) cells lack detectable miR-200c and E-cadherin (the latter reportedly due to promoter region methylation) but express TCF8. The ectopic expression of miR-200c in this cell line also reduced levels of TCF8, restored E-cadherin expression, and altered cell morphology. Because the down-regulation of E-cadherin is a crucial event in epithelial-to-mesenchymal transition, loss of miR-200c expression could play a significant role in the initiation of an invasive phenotype, and, equally, miR-200c overexpression holds potential for its reversal.
Similar articles
- Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression.
Hurteau GJ, Carlson JA, Roos E, Brock GJ. Hurteau GJ, et al. Cell Cycle. 2009 Jul 1;8(13):2064-9. doi: 10.4161/cc.8.13.8883. Epub 2009 Jul 29. Cell Cycle. 2009. PMID: 19502803 - microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
Wang X, Chen X, Wang R, Xiao P, Xu Z, Chen L, Hang W, Ruan A, Yang H, Zhang X. Wang X, et al. Oncol Rep. 2013 Aug;30(2):643-50. doi: 10.3892/or.2013.2530. Epub 2013 Jun 7. Oncol Rep. 2013. PMID: 23754305 - miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
Mutlu M, Raza U, Saatci Ö, Eyüpoğlu E, Yurdusev E, Şahin Ö. Mutlu M, et al. J Mol Med (Berl). 2016 Jun;94(6):629-44. doi: 10.1007/s00109-016-1420-5. Epub 2016 Apr 20. J Mol Med (Berl). 2016. PMID: 27094812 Review. - Targeting miR-205 in breast cancer.
Wu H, Mo YY. Wu H, et al. Expert Opin Ther Targets. 2009 Dec;13(12):1439-48. doi: 10.1517/14728220903338777. Expert Opin Ther Targets. 2009. PMID: 19839716 Review.
Cited by
- Fragile X protein family member FXR1P is regulated by microRNAs.
Cheever A, Blackwell E, Ceman S. Cheever A, et al. RNA. 2010 Aug;16(8):1530-9. doi: 10.1261/rna.2022210. Epub 2010 Jun 2. RNA. 2010. PMID: 20519410 Free PMC article. - MicroRNAs: novel biomarkers for gastrointestinal carcinomas.
Xie L, Qian X, Liu B. Xie L, et al. Mol Cell Biochem. 2010 Aug;341(1-2):291-9. doi: 10.1007/s11010-010-0463-0. Epub 2010 Apr 27. Mol Cell Biochem. 2010. PMID: 20422260 Review. - CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer.
Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, Chen N, Sun F, Fan Q. Wang J, et al. Nucleic Acids Res. 2010 Sep;38(16):5366-83. doi: 10.1093/nar/gkq285. Epub 2010 Apr 27. Nucleic Acids Res. 2010. PMID: 20423907 Free PMC article. - The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.
Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A, Brunton VG, Morton J, Sansom O, Schüler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T. Wellner U, et al. Nat Cell Biol. 2009 Dec;11(12):1487-95. doi: 10.1038/ncb1998. Epub 2009 Nov 22. Nat Cell Biol. 2009. PMID: 19935649 - Identification and analysis of miRNAs in human breast cancer and teratoma samples using deep sequencing.
Nygaard S, Jacobsen A, Lindow M, Eriksen J, Balslev E, Flyger H, Tolstrup N, Møller S, Krogh A, Litman T. Nygaard S, et al. BMC Med Genomics. 2009 Jun 9;2:35. doi: 10.1186/1755-8794-2-35. BMC Med Genomics. 2009. PMID: 19508715 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous